[ASAP] Development of an Arginine Anchored Nanoglobule with Retrograde Trafficking Inhibitor (Retro-2) for the Treatment of an Enterohemorrhagic < italic toggle="yes" > Escherichia coli < /italic > Outbreak

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.9b00727

Source: Molecular Pharmaceutics - September 6, 2019 Category: Drugs & Pharmacology Authors: Tasneem Gandhi, Manali Patki, Jing Kong, Jagadish Koya, Sabesan Yoganathan, Sandra Reznik, and Ketankumar Patel* Source Type: research